Tanya Coleman

1.3k citations

28 papers · 1.1k indexed · 1 hit paper · h-index 17

Molecular Biology
Oncology top 10%
Organic Chemistry
Pharmacology top 10%
Cellular and Molecular Neuroscience top 10%

Co-authors: Iain S. Haslam Paul R. Gavine Teresa Klinowska Elaine Kilgour Dawn Baker Andrew P. Thomas Lorraine Mooney Katherine Al-Kadhimi
Topics: Drug Transport and Resistance Mechanisms (9 papers)Pharmacological Effects and Toxicity Studies (6 papers)Inflammatory mediators and NSAID effects (6 papers)
Cited by: Pharmacology Oncology Molecular Biology
Journals: Journal of Clinical Oncology Cancer Research Journal of Pharmacology and Experimental Therapeutics
Partner nations: United Kingdom France Singapore

In The Last Decade

Tanya Coleman

28 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

AZD4547: An Orally Bioavailable, Potent, and Selective Inhibitor of the Fibroblast Growth Factor Receptor Tyrosine Kinase Family

2012 415 citations Paul R. Gavine, Lorraine Mooney et al. Cancer Research profile →

Peers

Countries citing papers authored by Tanya Coleman

Since Specialization

Citations

This map shows the geographic impact of Tanya Coleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tanya Coleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tanya Coleman more than expected).

Fields of papers citing papers by Tanya Coleman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tanya Coleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tanya Coleman. The network helps show where Tanya Coleman may publish in the future.

Co-authorship network of co-authors of Tanya Coleman

This figure shows the co-authorship network connecting the top 25 collaborators of Tanya Coleman. A scholar is included among the top collaborators of Tanya Coleman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tanya Coleman. Tanya Coleman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	AZD4547: An Orally Bioavailable, Potent, and Selective Inhibitor of the Fibroblast Growth Factor Receptor Tyrosine Kinase Familybreakdown → 2012 ·Cancer Research ·Paul R. Gavine,Lorraine Mooney,Elaine Kilgour,Andrew P. Thomas,Katherine Al-Kadhimi,Sarah Beck,Claire Rooney,Tanya Coleman,Dawn Baker,Martine J. Mellor,A. Nigel Brooks,Teresa Klinowska	415
2	Probabilistic Orthology Analysis of the ATP-Binding Cassette Transporters: Implications for the Development of Multiple Drug Resistance Phenotype 2012 ·Drug Metabolism and Disposition ·Ciarán Fisher,Tanya Coleman,Nick Plant	2
3	Pancreatoduodenectomy as a source of human small intestine for Ussing chamber investigations and comparative studies with rat tissue 2011 ·Biopharmaceutics & Drug Disposition ·Iain S. Haslam,Derek O’Reilly,David Sherlock,(unknown),Chris Womack,Tanya Coleman	48
4	The statin class of HMG-CoA reductase inhibitors demonstrate differential activation of the nuclear receptors PXR, CAR and FXR, as well as their downstream target genes 2011 ·Xenobiotica ·(unknown),(unknown),Alfred E. Thumser,Tanya Coleman,Nick Plant	50
5	Breast cancer resistance protein BCRP (ABCG2)-mediated transepithelial nitrofurantoin secretion and its regulation in human intestinal epithelial (Caco-2) layers 2011 ·European Journal of Pharmacology ·(unknown),Iain S. Haslam,Tanya Coleman,Nicholas L. Simmons	22
6	Inhibitors of the tyrosine kinase EphB4. Part 4: Discovery and optimization of a benzylic alcohol series 2011 ·Bioorganic & Medicinal Chemistry Letters ·Bernard Barlaam,Richard Ducray,Christine Lambert‐van der Brempt,Patrick A. Plé,Catherine Bardelle,Nigel Brooks,Tanya Coleman,Darren A.E. Cross,Jason G. Kettle,Jon Read	26
7	Compartmental modelling of the pharmacokinetics of a breast cancer resistance protein 2010 ·Computer Methods and Programs in Biomedicine ·Thomas Grandjean,(unknown),(unknown),Kevin F. Jones,Gemma Wood,Tanya Coleman	5
8	Inhibitors of the tyrosine kinase EphB4. Part 3: Identification of non-benzodioxole-based kinase inhibitors 2010 ·Bioorganic & Medicinal Chemistry Letters ·Catherine Bardelle,Bernard Barlaam,Nigel Brooks,Tanya Coleman,Darren A.E. Cross,Richard Ducray,Isabelle Green,Christine Lambert‐van der Brempt,Annie Olivier,Jon Read	30
9	Induction of P-glycoprotein expression and function in human intestinal epithelial cells (T84) 2008 ·Biochemical Pharmacology ·Iain S. Haslam,Karen L. Jones,Tanya Coleman,N. L. Simmons	56
10	In Silico and in Vitro Modeling of Hepatocyte Drug Transport Processes: Importance of ABCC2 Expression Levels in the Disposition of Carboxydichlorofluroscein 2008 ·Drug Metabolism and Disposition ·(unknown),G. Gordon Gibson,Tanya Coleman,Nick Plant	9
11	Rifampin and digoxin induction of MDR1 expression and function in human intestinal (T84) epithelial cells 2008 ·British Journal of Pharmacology ·Iain S. Haslam,Karen L. Jones,Tanya Coleman,N. L. Simmons	38
12	Design and synthesis of 6-phenylnicotinamide derivatives as antagonists of TRPV1 2008 ·Bioorganic & Medicinal Chemistry Letters ·Susan M. Westaway,Mervyn Thompson,Harshad K. Rami,Geoffrey Stemp,Leendert A. Trouw,Darren J. Mitchell,(unknown),Stephen J. Medhurst,Sarah C. Lappin,James E. Biggs,Jim Wright,(unknown),Jeffrey C. Jerman,(unknown),Vicky Holland,Kim Winborn,Tanya Coleman,Alexander J. Stevens,John B. Davis,Martin J. Gunthorpe	35
13	1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists: Structure–activity relationships of 4- and 5-substituted benzoic acid derivatives 2006 ·Bioorganic & Medicinal Chemistry Letters ·Adrian Hall,Susan H. Brown,Iain P. Chessell,A. R. Chowdhury,(unknown),Tanya Coleman,Gerard M.P. Giblin,Beverley Hammond,Mark P. Healy,Matthew R. Johnson,(unknown),Anton D. Michel,Alan Naylor,Riccardo Novelli,David J. Spalding,(unknown)	9
14	Structure–activity relationships of 1,5-biaryl pyrroles as EP1 receptor antagonists 2006 ·Bioorganic & Medicinal Chemistry Letters ·Adrian Hall,Stephen J. Atkinson,Susan H. Brown,Iain P. Chessell,A. R. Chowdhury,(unknown),Tanya Coleman,Gerard M.P. Giblin,Robert J. Gleave,Beverley Hammond,Mark P. Healy,Matthew R. Johnson,Anton D. Michel,Alan Naylor,Riccardo Novelli,David J. Spalding,(unknown)	21
15	Discovery of novel biaryl heterocyclic EP1 receptor antagonists 2006 ·Bioorganic & Medicinal Chemistry Letters ·Adrian Hall,Rino A. Bit,Susan H. Brown,(unknown),Iain P. Chessell,Tanya Coleman,Gerard M.P. Giblin,David N. Hurst,(unknown),Xiao Qing Lewell,Anton D. Michel,(unknown),Alan Naylor,Riccardo Novelli,(unknown),David J. Spalding,(unknown),Richard J. Wilson	16
16	1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists. Structure–activity relationships of 6-substituted and 5,6-disubstituted benzoic acid derivatives 2006 ·Bioorganic & Medicinal Chemistry Letters ·Adrian Hall,Susan H. Brown,Iain P. Chessell,A. R. Chowdhury,(unknown),Tanya Coleman,Gerard M.P. Giblin,Beverley Hammond,Mark P. Healy,Matthew R. Johnson,(unknown),Anton D. Michel,Alan Naylor,Riccardo Novelli,David J. Spalding,(unknown),(unknown)	12
17	Identification of novel pyrazole acid antagonists for the EP1 receptor 2006 ·Bioorganic & Medicinal Chemistry Letters ·Stephen C. McKeown,Adrian Hall,Gerard M.P. Giblin,Olivier Lorthioir,(unknown),Xiao Qing Lewell,Richard J. Wilson,Susan H. Brown,A. R. Chowdhury,Tanya Coleman,Steve P. Watson,Iain P. Chessell,Adrian Pipe,Nick M. Clayton,Paul Goldsmith	20
18	The discovery of 6-[2-(5-chloro-2-{[(2,4-difluorophenyl)methyl]oxy}phenyl)-1-cyclopenten-1-yl]-2-pyridinecarboxylic acid, GW848687X, a potent and selective prostaglandin EP1 receptor antagonist for the treatment of inflammatory pain 2006 ·Bioorganic & Medicinal Chemistry Letters ·Gerard M.P. Giblin,Rino A. Bit,Susan H. Brown,(unknown),A. R. Chowdhury,Iain P. Chessell,(unknown),Tanya Coleman,Adrian Hall,Beverley Hammond,David N. Hurst,Anton D. Michel,Alan Naylor,Riccardo Novelli,Tiziana Scoccitti,David J. Spalding,(unknown),Alex Wilson,(unknown)	42
19	Identification of a novel series of selective 5-HT7 receptor antagonists 2003 ·Bioorganic & Medicinal Chemistry Letters ·Ian T. Forbes,David G. Cooper,(unknown),(unknown),Andrew D. Gribble,Robert J. Ife,Andrew P. Lightfoot,(unknown),(unknown),Tanya Coleman,Graham J. Riley,David R. Thomas	16
20	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is N-demethylated by cytochromes P450 2D6, 1A2 and 3A4--implications for susceptibility to Parkinson's disease. 1996 ·Journal of Pharmacology and Experimental Therapeutics ·Tanya Coleman,S. W. Ellis,Ian Martin,M. S. Lennard,GT Tucker	76

About Tanya Coleman

Tanya Coleman is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Oncology, having authored 28 papers that have together received 1.1k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (9 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Inflammatory mediators and NSAID effects (6 papers). The work is most often cited by research in Pharmacology (115 citations), Oncology (282 citations) and Molecular Biology (589 citations). Tanya Coleman has collaborated with scholars based in United Kingdom, France and Singapore. Frequent co-authors include Iain S. Haslam, Paul R. Gavine, Teresa Klinowska, Elaine Kilgour, Dawn Baker, Andrew P. Thomas, Lorraine Mooney, Katherine Al-Kadhimi, Sarah Beck and Martine J. Mellor. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact